Gene · 406921
Papers4,561
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,821 to 1,840 of 4,561
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Potential Importance of MicroRNAs as Novel Indicators How to Manage Patients with Juvenile Idiopathic Arthritis More Effectively. | J Immunol Res | 2021 | 33575364 | PubTator, text mining | PubMed |
| MicroRNA Modulation of Host Immune Response and Inflammation Triggered by Helicobacter pylori. | Int J Mol Sci | 2021 | 33573346 | PubTator, text mining | PubMed |
| Epigenetics of Alzheimer's Disease. | Biomolecules | 2021 | 33573255 | PubTator, text mining | PubMed |
| MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review. | Cancers (Basel) | 2021 | 33572780 | PubTator, text mining | PubMed |
| Control of Gene Expression by Exosome-Derived Non-Coding RNAs in Cancer Angiogenesis and Lymphangiogenesis. | Biomolecules | 2021 | 33572413 | PubTator, text mining | PubMed |
| Role of Exosomal miRNA in Bladder Cancer: A Promising Liquid Biopsy Biomarker. | Int J Mol Sci | 2021 | 33567779 | PubTator, text mining | PubMed |
| miR-132 mediates cell permeability and migration by targeting occludin in high-glucose -induced ARPE-19 cells. | Endocr J | 2021 | 33563844 | PubTator, text mining | PubMed |
| The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis. | Cells | 2021 | 33562569 | PubTator, text mining | PubMed |
| Circulating level of microRNA-142-5p is a potential biomarker for predicting in-stent restenosis: a case-control study. | BMC Cardiovasc Disord | 2021 | 33557763 | PubTator, text mining | PubMed |
| Mir-1, miR-122, miR-132, and miR-133 Are Related to Subclinical Aortic Atherosclerosis Associated with Metabolic Syndrome. | Int J Environ Res Public Health | 2021 | 33557426 | PubTator, text mining | PubMed |
| What, When and How to Measure-Peripheral Biomarkers in Therapy of Huntington's Disease. | Int J Mol Sci | 2021 | 33557131 | PubTator, text mining | PubMed |
| Targeting the Hippo Pathway in Prostate Cancer: What's New? | Cancers (Basel) | 2021 | 33557087 | PubTator, text mining | PubMed |
Differential effects on the miRNome of the treatment of human airway epithelial Calu-3 cells with peptide-nucleic acids (PNAs) targeting microRNAs miR-101-3p and miR-145-5p: Next generation sequencing datasets. | Data Brief | 2021 | 33553515 | PubTator, text mining | PubMed |
| Oxidative Stress-Related Mechanisms in Schizophrenia Pathogenesis and New Treatment Perspectives. | Oxid Med Cell Longev | 2021 | 33552387 | PubTator, text mining | PubMed |
| MeCP2: The Genetic Driver of Rett Syndrome Epigenetics. | Front Genet | 2021 | 33552148 | PubTator, text mining | PubMed |
| Molecular characterization of atherosclerosis in HIV positive persons. | Sci Rep | 2021 | 33547350 | PubTator, text mining | PubMed |
| NLRP3 Inflammasome at the Interface of Inflammation, Endothelial Dysfunction, and Type 2 Diabetes. | Cells | 2021 | 33546399 | PubTator, text mining | PubMed |
| Unraveling Molecular Pathways Altered in MeCP2-Related Syndromes, in the Search for New Potential Avenues for Therapy. | Biomedicines | 2021 | 33546327 | PubTator, text mining | PubMed |
| In vivo effects of olive oil and trans-fatty acids on miR-134, miR-132, miR-124-1, miR-9-3 and mTORC1 gene expression in a DMBA-treated mouse model. | PLoS One | 2021 | 33539381 | PubTator, text mining | PubMed |
| Hypoxia-induced Nur77 activates PI3K/Akt signaling via suppression of Dicer/let-7i-5p to induce epithelial-to-mesenchymal transition. | Theranostics | 2021 | 33537093 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406921/papers?page=92